Jianli Cao

3.9k total citations · 1 hit paper
30 papers, 829 citations indexed

About

Jianli Cao is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Jianli Cao has authored 30 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Jianli Cao's work include Respiratory viral infections research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Jianli Cao is often cited by papers focused on Respiratory viral infections research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Jianli Cao collaborates with scholars based in China, Hong Kong and United States. Jianli Cao's co-authors include Jasper Fuk‐Woo Chan, Shuofeng Yuan, Hin Chu, Kwok‐Yung Yuen, Kaiming Tang, Jian‐Piao Cai, Ronghui Liang, Kelvin Kai‐Wang To, Vincent Kwok‐Man Poon and Cuiting Luo and has published in prestigious journals such as Nature Communications, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Jianli Cao

27 papers receiving 815 citations

Hit Papers

Surgical Mask Partition R... 2020 2026 2022 2024 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)
    2020 400 citations Jasper Fuk‐Woo Chan, Shuofeng Yuan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianli Cao China 12 470 152 146 142 96 30 829
Ronghui Liang China 13 507 1.1× 185 1.2× 131 0.9× 154 1.1× 104 1.1× 22 910
Kaiming Tang Hong Kong 14 505 1.1× 153 1.0× 110 0.8× 119 0.8× 100 1.0× 33 856
Laura Baseler United States 13 718 1.5× 286 1.9× 184 1.3× 88 0.6× 77 0.8× 18 1.2k
Fengting Yu China 12 763 1.6× 212 1.4× 131 0.9× 91 0.6× 87 0.9× 38 1.1k
Cuiting Luo China 8 365 0.8× 82 0.5× 71 0.5× 106 0.7× 87 0.9× 18 575
So Yeon Kim South Korea 14 586 1.2× 160 1.1× 128 0.9× 68 0.5× 91 0.9× 39 891
Hulda R. Jónsdóttir Switzerland 13 414 0.9× 103 0.7× 129 0.9× 112 0.8× 36 0.4× 23 808
Yen‐Ta Lu Taiwan 15 244 0.5× 115 0.8× 130 0.9× 111 0.8× 47 0.5× 40 698
Kangtai Liu China 6 636 1.4× 262 1.7× 137 0.9× 67 0.5× 144 1.5× 8 1.1k
Nikolaos C. Kyriakidis Ecuador 14 572 1.2× 261 1.7× 80 0.5× 41 0.3× 85 0.9× 28 1.2k

Countries citing papers authored by Jianli Cao

Since Specialization
Citations

This map shows the geographic impact of Jianli Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianli Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianli Cao more than expected).

Fields of papers citing papers by Jianli Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianli Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianli Cao. The network helps show where Jianli Cao may publish in the future.

Co-authorship network of co-authors of Jianli Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Jianli Cao. A scholar is included among the top collaborators of Jianli Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianli Cao. Jianli Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Tiansheng, Yan Xiang, Yuanchun Zhang, et al.. (2025). An effective strategy for regulating SiOx/Si components by thermal reduction of biomass diatomite for lithium-ion battery anodes. Journal of Energy Storage. 138. 118704–118704.
2.
3.
Cao, Jianli, Yan Xiang, Dan Li, et al.. (2024). In situ construction of ion/electron conductive components via lithiation strategy enhancing cycling capability and initial Coulombic efficiency of Si anode. Chemical Engineering Journal. 504. 159049–159049. 8 indexed citations
4.
Cao, Jianli, et al.. (2024). Oroxylin A suppressed colorectal cancer metastasis by inhibiting the activation of the TGF-β/SMAD signal pathway. Scientific Reports. 14(1). 24091–24091. 2 indexed citations
5.
Chu, Zhaohui, et al.. (2024). [Advances in prostate cancer biomarkers].. PubMed. 40(11). 3951–3973. 1 indexed citations
6.
Liang, Ronghui, Zi‐Wei Ye, Zhenzhi Qin, et al.. (2024). PMI-controlled mannose metabolism and glycosylation determines tissue tolerance and virus fitness. Nature Communications. 15(1). 2144–2144. 11 indexed citations
7.
Cao, Jianli, et al.. (2024). Xuebijing and somatostatin against acute pancreatitis: A systematic review and network pharmacology. Medicine. 103(50). e40964–e40964. 1 indexed citations
8.
Liao, Qiuying, Shuofeng Yuan, Jianli Cao, et al.. (2021). Inhaled Dry Powder Formulation of Tamibarotene, a Broad‐Spectrum Antiviral against Respiratory Viruses Including SARS‐CoV‐2 and Influenza Virus. Advanced Therapeutics. 4(7). 17 indexed citations
9.
Wen, Lei, Kaiming Tang, Kenn Ka‐Heng Chik, et al.. (2021). In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor. International Journal of Biological Sciences. 17(6). 1555–1564. 11 indexed citations
10.
Cao, Jianli, Gang Lu, Lei Wen, et al.. (2021). Severe fever with thrombocytopenia syndrome virus (SFTSV)-host interactome screen identifies viral nucleoprotein-associated host factors as potential antiviral targets. Computational and Structural Biotechnology Journal. 19. 5568–5577. 9 indexed citations
11.
Yuan, Shuofeng, Hin Chu, Jingjing Huang, et al.. (2020). Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target. Science Advances. 6(35). eaba7910–eaba7910. 41 indexed citations
12.
Yuan, Shuofeng, Jasper Fuk‐Woo Chan, Chris Chun-Yiu Chan, et al.. (2020). Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacological Research. 159. 104960–104960. 47 indexed citations
13.
Zou, Zijiao, Jessica Oi‐Ling Tsang, Bingpeng Yan, et al.. (2020). Metabolic Profiling Reveals Significant Perturbations of Intracellular Glucose Homeostasis in Enterovirus-Infected Cells. Metabolites. 10(8). 302–302. 12 indexed citations
14.
Yuan, Shuofeng, Chris Chun-Yiu Chan, Ronghui Liang, et al.. (2020). Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19). Viruses. 12(6). 628–628. 47 indexed citations
15.
Yuan, Shuofeng, Jasper Fuk‐Woo Chan, Zi‐Wei Ye, et al.. (2019). Screening of an FDA-Approved Drug Library with a Two-Tier System Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia Syndrome Virus. Viruses. 11(4). 385–385. 18 indexed citations
16.
Sun, Yongpeng, Wei Zhang, Qinjian Zhao, et al.. (2018). An optimized high-throughput fluorescence plate reader-based RSV neutralization assay. Journal of Virological Methods. 260. 34–40. 2 indexed citations
17.
Lee, Sung, et al.. (2011). Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 460(2). 141–149. 45 indexed citations
18.
Leckie, Gregor, et al.. (1998). Method for Reduction of Inhibition in a Mycobacterium tuberculosis -Specific Ligase Chain Reaction DNA Amplification Assay. Journal of Clinical Microbiology. 36(3). 764–767. 6 indexed citations
19.
20.
Lorimer, Donald D., Jianli Cao, & Arnold Revzin. (1990). Specific sequences downstream from −6 are not essential for proper and efficient in Vitro utilization of the Escherichia coli lactose promoter. Journal of Molecular Biology. 216(2). 275–287. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronghui Liang Breakdown of academic impact, for papers by Kaiming Tang Breakdown of academic impact, for papers by Laura Baseler Breakdown of academic impact, for papers by Fengting Yu Breakdown of academic impact, for papers by Cuiting Luo Breakdown of academic impact, for papers by So Yeon Kim Breakdown of academic impact, for papers by Hulda R. Jónsdóttir Breakdown of academic impact, for papers by Yen‐Ta Lu Breakdown of academic impact, for papers by Kangtai Liu Breakdown of academic impact, for papers by Nikolaos C. Kyriakidis
Rankless by CCL
2026